Innate Pharma S.A. (NASDAQ:IPHA) reported a €19.6 million first-half net loss on September 17, following the closing of its lacutamab partnership with Sobi a day earlier. The closing triggered a $75 million upfront payment. Management projects funding through the end…
TOP HEADLINES
Sports
Nvidia announced its new Open Agent Safety Platform on Monday with 100…
A newly published study estimates that Republican fundraisers lost $117 million last…
OpenAI has told dozens of government agencies, universities and other organizations that…
Stanford University has apologized for using AI to swap out a Hispanic…